IRIS
GRIMALDI, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.536
EU - Europa 1.209
NA - Nord America 1.068
SA - Sud America 206
AF - Africa 53
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
Totale 4.075
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.007
SG - Singapore 778
RU - Federazione Russa 581
CN - Cina 386
IT - Italia 241
BR - Brasile 181
VN - Vietnam 121
HK - Hong Kong 110
DE - Germania 84
GB - Regno Unito 51
NL - Olanda 50
FI - Finlandia 47
IN - India 42
CA - Canada 34
IE - Irlanda 29
KR - Corea 25
CI - Costa d'Avorio 24
FR - Francia 22
SE - Svezia 22
UA - Ucraina 20
MX - Messico 18
BD - Bangladesh 16
ZA - Sudafrica 15
AT - Austria 14
PL - Polonia 14
AR - Argentina 10
ES - Italia 9
LT - Lituania 9
JP - Giappone 8
ID - Indonesia 7
PK - Pakistan 7
TR - Turchia 7
EC - Ecuador 6
IQ - Iraq 6
AE - Emirati Arabi Uniti 5
CL - Cile 5
CZ - Repubblica Ceca 5
BE - Belgio 4
KE - Kenya 4
UZ - Uzbekistan 4
CH - Svizzera 3
IL - Israele 3
JM - Giamaica 3
EU - Europa 2
KZ - Kazakistan 2
MA - Marocco 2
NP - Nepal 2
AU - Australia 1
AZ - Azerbaigian 1
BO - Bolivia 1
BS - Bahamas 1
CO - Colombia 1
CR - Costa Rica 1
EG - Egitto 1
GA - Gabon 1
HN - Honduras 1
HR - Croazia 1
JO - Giordania 1
KW - Kuwait 1
LC - Santa Lucia 1
LU - Lussemburgo 1
ML - Mali 1
MR - Mauritania 1
MW - Malawi 1
MY - Malesia 1
OM - Oman 1
PA - Panama 1
PH - Filippine 1
PY - Paraguay 1
RE - Reunion 1
RO - Romania 1
SI - Slovenia 1
SN - Senegal 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
YE - Yemen 1
Totale 4.075
Salva come PNG Salva come JPEG
Città #
Singapore 376
Moscow 155
Hefei 134
Chandler 124
Ashburn 110
Hong Kong 110
Beijing 86
Naples 72
Santa Clara 58
Ho Chi Minh City 45
Los Angeles 41
Amsterdam 34
Millbury 34
Munich 30
Dong Ket 28
New York 28
Seoul 23
Napoli 22
Des Moines 18
Princeton 18
Redondo Beach 18
Boston 15
Nanjing 15
São Paulo 14
Hanoi 13
Helsinki 13
Milan 13
Stockholm 13
The Dalles 13
Turku 13
Buffalo 12
Denver 11
Kochi 11
London 11
Ottawa 11
San Jose 11
Dallas 10
Lawrence 10
Warsaw 10
Frankfurt am Main 9
Montreal 9
Seattle 9
Poplar 8
Redwood City 8
Rome 8
Tokyo 8
Chennai 7
Chicago 7
Falkenstein 7
Houston 7
Nanchang 7
Porto Alegre 7
Wilmington 7
Atlanta 6
Brooklyn 6
Johannesburg 6
Mexico City 6
New Delhi 6
Nuremberg 6
Phoenix 6
Rio de Janeiro 6
Toronto 6
Campagna 5
Dublin 5
Lappeenranta 5
Querétaro 5
Quito 5
San Francisco 5
Shenyang 5
Tianjin 5
Vienna 5
Brasília 4
Brussels 4
Changsha 4
Florence 4
Istanbul 4
Norwalk 4
Orem 4
Salvador 4
Tashkent 4
Ankara 3
Aracaju 3
Baghdad 3
Bengaluru 3
Cape Town 3
Casapulla 3
Dhaka 3
Florianópolis 3
Goiânia 3
Hamilton 3
Manchester 3
Nairobi 3
Nanning 3
Ostrava 3
Paris 3
Pozzuoli 3
Rose 3
Roubaix 3
Santiago 3
Sete Lagoas 3
Totale 2.086
Salva come PNG Salva come JPEG
Nome #
(1-3)-β-d-Glucan serum increase and small-airway-invasive radiological findings as early signs of pulmonary aspergillosis in high-risk hematologic patients in the posaconazole era: preliminary observations 152
A Frontline Approach With Peripherally Inserted Versus Centrally Inserted Central Venous Catheters for Remission Induction Chemotherapy Phase of Acute Myeloid Leukemia: A Randomized Comparison 148
JAK2V617F mutation persists in blasts and mature cells of transformed JAK2V617F-positive-myeloproliferative neoplasia: a European Leukemia Net (ENL) study. 127
Intravascular Complications of Central Venous Catheterization by Insertion Site in Acute Leukemia during Remission Induction Chemotherapy Phase: Lower Risk with Peripherally Inserted Catheters in a Single-Center Retrospective Study 126
LONG-TERM FOLLOW UP OF ALENTUZUMAB-BASED IMMUNOSUPPRESSION FOR THE TREATMENT OF IMMUNE-MEDIATED BONE MARROW FAILURE SYNDROMES 119
Fine needle aspiration cytology and flow cytometry immunophenotyping of non-Hodgkin lymphoma: can we do better?. 118
Acute immune toxicity during anti-thymocyte globulin: That's CARPA! 117
Twenty years of the Italian Fanconi Anemia Registry: Where we stand and what remains to be learned 116
Excellent outcome of concomitant intensive immunosuppression and eculizumab in aplastic anemia/paroxysmal nocturnal hemoglobinuria syndrome. 114
Contrast-enhanced harmonic compound US of the spleen to increase staging accuracy in patients with Hodgkin lymphoma: a prospective study. 112
Adding hydroxyurea in combination with ruxolitinib improves clinical responses in hyperproliferative forms of myelofibrosis 112
Early combination of sotrovimab with nirmatrelvir/ritonavir or remdesivir is associated with low rate of persisting SARS CoV-2 infection in immunocompromised outpatients with mild-to-moderate COVID-19: a prospective single-centre study 110
Myeloid Sarcoma of the Breast as Blast Phase of JAK2-Mutated (Val617Phe Exon 14p) Essential Thrombocythemia: A Case Report and a Systematic Literature Review 110
PEGYLATED-FILGRASTIM AFTER AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION: SINGLE CENTRE EXPERIENCE 109
1139 poster ASYMPTOMATIC HEART DISEASE AFTER MEDIASTINAL IRRADIATION IN HODGKIN'S LYMPHOMA: PRELIMINARY FINDINGS 106
PEG-FILGRASTIM AFTER AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION : A SINGLE-CENTRE EXPERIENCE 104
Retroperitoneal extramedullary relapse after blinatumomab in acute lymphoblastic leukemia failing haplo-identical bone marrow transplantation. 104
XM02 PLUS CHEMOTHERAPY IS SAFE AND EFFECTIVE IN STEM CELL MOBILIZATION FOR PATIENTS CANDIDATED TO AUTOLOGOUS STEM CELL TRANSPLANTATION 103
THIOTEPA AND MELPHALAN AS NEW CONDITIONING REGIMEN FOR AUTOLOGOUS TRANSPLANTATION IN MULTIPLE LYELOMA 100
Fine needle aspiration cytology and flow cytometry immunophenotyping of non-Hodgkin lymphoma: can we do better? 97
Efficacy and safety of rituximab treatment in patients with progressive transformation of germinal centers after Hodgkin lymphoma in complete remission post-induction chemotherapy and radiotherapy. 97
Thyroid V30 Predicts Radiation-Induced Hypothyroidism in Patients Treated With Sequential Chemo-Radiotherapy for Hodgkin’s Lymphoma 96
Limited efficacy of 3 + 7 plus gemtuzumab ozogamycin in newly diagnosed fit intermediate genetic risk acute myeloid leukemia patients 93
Fused FDG-PET/contrast-enhanced CT detects occult subdiaphragmatic involvement of Hodgkin's lymphoma thereby identifying patients requiring six cycles of anthracycline-containing chemotherapy and consolidation radiation of spleen. 91
Long-term Cryopreserved Autologous Hematopoietic Stem Cells Following Azacytidine to Successfully Treat Severe Invasive Pulmonary Aspergillosis After Therapy-Related Myelodysplastic Syndrome and CD8+ T-cell Autoimmune Disorders: A Case Report 90
Epidemiology of Acquired Bone Marrow Failure 89
Sequential continuous infusion of fludarabine and cytarabine associated with liposomal daunorubicin (DaunoXome®) (FLAD) in primary refractory or relapsed adult acute myeloid leukemia patients 88
COVID-19 infection in acute lymphoblastic leukemia over 15 months of the pandemic. A Campus ALL report 86
The Q-LAMP Method Represents a Valid and Rapid Alternative for the Detection of the BCR-ABL1 Rearrangement in Philadelphia-Positive Leukemias 84
Deregulation of New Cell Death Mechanisms in Leukemia 82
New scenarios in Vacuoles, E1 enzyme, X linked, Autoinflammatory, Somatic (VEXAS) syndrome: Evolution from myelodysplastic syndrome to acute myeloid leukemia 80
Successful treatment of MDR Stenotrophomonas maltophilia-associated pneumonia with cefiderocol-based regimen in a patient with hematological malignancy 71
Similar outcomes of alemtuzumab-based hematopoietic cell transplantation for SAA patients older or younger than 50 years 70
Outcome of 421 adult patients with Philadelphia-negative acute lymphoblastic leukemia treated under an intensive program inspired by the GIMEMA LAL1913 clinical trial: a Campus ALL study 69
Molecular analysis of T-cell Acute Lymphoblastic Leukemia arising after Essential Thrombocythemia foreshadows a distinct clonal route for lymphoid blast crisis in Philadelphia-negative chronic myeloproliferative neoplasm: a case report with literary review 69
Caspofungin for Primary Antifungal Prophylaxis in Acute Myeloid Leukemia: A Real-Life Study from an Academic Center 65
CPX-351 treatment in secondary acute myeloblastic leukemia is effective and improves the feasibility of allogeneic stem cell transplantation: results of the Italian compassionate use program 63
Up-front Blinatumomab Improves MRD Clearance and Outcome in Adult Ph- B-lineage ALL: the GIMEMA LAL2317 Phase 2 Study 62
Long-term real world evidence of CPX-351 of high-risk AML patients identified high rate of negative MRD and prolonged OS 57
Nonmyeloablative Peripheral Blood Haploidentical Stem Cell Transplantation for Refractory Severe Aplastic Anemia 53
Full donor chimerism without graft-versus-host disease: the key factor for maximum benefit of pre-emptive donor lymphocyte infusions (pDLI) 53
Hypomethylating Agents (HMAs) as Salvage Therapy in Relapsed or Refractory AML: An Italian Multicentric Retrospective Study 50
Mixed T Cell Chimerism After Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia Using an Alemtuzumab-Containing Regimen Is Shaped by Persistence of Recipient CD8 T Cells 46
Gallbladder Myeloid Sarcoma Associated With NPM1 Mutated Acute Myeloid Leukemia 40
The role of ponatinib in adult BCR-ABL1 positive acute lymphoblastic leukemia after allogeneic transplantation: a real-life retrospective multicenter study 39
Blinatumomab differentially modulates peripheral blood and bone marrow immune cell repertoire: A Campus ALL study 33
Luspatercept treatment affects immune-regulatory subsets in patients with MDS with ring sideroblasts 24
Real-world multicenter analysis of CPX-351 efficacy in patients aged less than 60 years with secondary acute myeloid leukemia 18
Totale 4.162
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.798
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.798
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202148 0 0 0 0 0 0 1 2 3 9 3 30
2021/2022213 3 4 2 2 3 7 3 4 26 20 69 70
2022/2023295 28 14 10 9 52 42 2 38 52 31 13 4
2023/2024155 5 33 13 7 8 19 5 32 0 0 24 9
2024/20251.347 35 36 25 22 39 91 153 111 73 152 493 117
2025/20261.845 311 243 337 320 538 81 15 0 0 0 0 0
Totale 4.162